Europe OTC Parasiticides Market Share

  • Report ID: 4682
  • Published Date: Jan 13, 2023
  • Report Format: PDF, PPT

Europe OTC Parasiticides Industry - Regional Synopsis

The Europe OTC parasiticides market is segmented into Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, and Rest of Europe (EU 27). Amongst all, the Rest of Europe market in all the other regions is projected to hold the largest market share of USD 180.1 million by the end of 2031. The market in the region is to display growth at a CAGR of 5.59% over the forecast period. In 2021, the region garnered a revenue of USD 104.90 million. The growth of the market can be attributed majorly to the higher number of vets present across the several countries in the region followed by increased expenditure on pet care. A higher number of vets can help people to prescribe the best solution for the parasite-infected area and create awareness about parasiticides among pet owners or social workers. There are nearly 29,000 vets in the United Kingdom. Moreover, nearly USD 6 billion is spent annually on veterinary services by UK pet owners. Additionally, there are more than 12 million households and around 50 million pet owners in the United States. Cats are the second most popular pet after dogs.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Increased demand for parasiticides, rising empathy for animals, and higher count of livestock are the few factors which is likely to boost the market growth.

The market is anticipated to attain a CAGR of 6.26% over the forecast period, i.e., 2022-2031.

Illegal selling of parasiticides and risk of parasiticides impacting human health and other invertebrates are the few factors that are to hamper the market growth.

The market in rest of Europe is projected to hold the largest market share of USD 180.1 million by the end of 2031 and provide more business opportunities in the future. The market in the region to grow at a CAGR of 5.59% over the forecast period. In 2021, the region garnered a revenue of USD 104.90 million.

The major players in the market are Inovet, Merck & Co., Inc., Chanelle Pharma, Ceva Sante Animale, Vetoquinol S.A., Boehringer Ingelheim International GmbH, PetlQ, LLC., Syndel, Elanco Animal Health Incorporated, and Others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, animal, end user, distribution channel, and by country.

The dog segment is anticipated to garner the largest market size of USD 286.02 million by the end of 2031 and display significant growth opportunities. The segment is to grow at a CAGR of 6.47% over the forecast period. The segment garnered a revenue of USD 153.46 million in 2021.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos